Author:
O’Brien G. C.,Cahill R. A.,Bouchier-Hayes D. J.,Redmond H. P.
Publisher
Springer Science and Business Media LLC
Reference25 articles.
1. Sharpless SM, Das Gupta TK. Surgery for metastatic melanoma.Semin Surg Oncol 1998; 14 (4): 311–8.
2. Philip PA, Flaherty L. Treatment of malignant melanoma with interleukin-2.Semin Oncol 1997; 24 (4): S32–8.
3. Kammula US, White DE, Rosenberg SA. Trends in the safety of high bolus Interleukin-2 administration in patients with metastatic cancer.Cancer 1998; 83(4): 797–805.
4. Mier JW. Abrogation of IL-2 toxicity. In:Therapeutic applications of Interleukin-2. New York, Marcel Dekker Inc., 1995; p 455–475.
5. Sznol M, Thurn A Aronson FR. Interleukin-2 in combination with other biologic agents. In: Therapeutic applications of Interleukin-2. New York, Marcel Dekker Inc., 1993: p 233–75.
Cited by
21 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献